The CROCO Study: CROhn's Disease COhort Study
The investigators propose to create a prospective Crohn Disease cohort, where patients receiving the most up-to-date therapies with a treat-to-target strategy, will be closely followed to characterize the progression of Crohn Disease by measuring the Lémann Index over time. The goal of the CROCO Study - Crohn's Disease Cohort Study is to promote a greater understanding of the long-term evolution of Crohn Disease , to describe prospectively the impact of different therapeutic strategies and develop accurate predictors of bowel disease damage and disability.
⁃ To be eligible all of the following criteria must be met:
• Diagnosis of CD (according to ECCO guidelines) established within the past 12 months;
• Patients able to understand the information provided to them and to give written informed consent for the study;
• Male or female, age \> 18 years.